Qiming Venture Partners — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
Allorion Therapeuticsalloriontx.comin𝕏Mar 2023 · $50M
Allorion Therapeutics is a biotech company developing next-generation targeted small-molecule drugs for human diseases, using data-driven discovery platforms and partnerships with pharmaceutical companies for commercialization.
BiotechHealthtech
Co-investorsINCE Capital
Deepwaydeepway.comMar 2023 · $112M
DeepWay (深向) develops new-energy heavy-duty trucks and autonomous driving technology aimed at building unmanned freight robots (RoboTrucks) for logistics fleets.
AI & Machine LearningLogistics & Supply ChainMobility & TransportationBeijing, CN
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.